Galambos J T, Hollingsworth M A, Falek A, Warren W D, McCain J R
J Clin Invest. 1977 Jul;60(1):107-14. doi: 10.1172/JCI108746.
Adult human liver biopsies were cultured from normal, alcoholic hepatitis, chronic active hepatitis, fibrosis plus alcoholic hepatitis (active cirrhosis), inactive cirrhosis, and drug hepatitis. The synthesis of collagen was estimated in cultures from 58 livers by measuring the conversion of [(14)C]proline to the [(14)C]hydroxyproline of collagen; that of glycosaminoglycans in cultures from 57 livers by the incorporation of [(3)H]acetate and (35)SO(4) into glycosaminoglycans (GAG). The synthesis of procollagen was increased only in cultures from alcoholic hepatitis, both in the pulse medium (P < 0.05) and in the chase medium (P < 0.02). The synthesis of insoluble collagen was increased in cultures from chronic (active) hepatitis (P < 0.01), fibrosis plus alcoholic hepatitis (active cirrhosis) (P < 0.001), and inactive cirrhosis (P < 0.05). Essentially all radioactive GAG was soluble in culture media. The predominant GAG were chondroitin-4 or -6-SO(4). The synthesis of GAG was increased only in cultures from fibrosis plus alcoholic hepatitis (active cirrhosis) both in the pulse medium (P < 0.01) and chase medium (P < 0.001). The data indicate that in the absence of immuno-competent cells or their secretory products, tissue cultures from livers showing biopsy evidence of active fibrosis in vivo may demonstrate increased synthesis of collagen and GAG in vitro. Increased (soluble) procollagen synthesis in cultures from alcoholic hepatitis was not associated with histologically demonstrable overt hepatic fibrosis in vivo, nor was it associated with increased GAG synthesis in vitro. No significant difference was demonstrable in collagen or GAG synthesis in paired cultures which contained either 300 mg/dl ethanol or 3.75 mg/dl methylprednisolone compared to their respective controls.
从正常、酒精性肝炎、慢性活动性肝炎、纤维化合并酒精性肝炎(活动性肝硬化)、静止性肝硬化和药物性肝炎患者获取成人肝脏活检组织进行培养。通过测量[(14)C]脯氨酸向胶原蛋白[(14)C]羟脯氨酸的转化,对58例肝脏培养物中的胶原蛋白合成进行评估;通过将[(3)H]乙酸盐和(35)SO(4)掺入糖胺聚糖(GAG),对57例肝脏培养物中的糖胺聚糖合成进行评估。仅在酒精性肝炎培养物中,脉冲培养基(P < 0.05)和追踪培养基(P < 0.02)中的前胶原蛋白合成均增加。慢性(活动性)肝炎(P < 0.01)、纤维化合并酒精性肝炎(活动性肝硬化)(P < 0.001)和静止性肝硬化(P < 0.05)培养物中的不溶性胶原蛋白合成增加。基本上所有放射性GAG均可溶于培养基。主要的GAG是硫酸软骨素-4或-6。仅在纤维化合并酒精性肝炎(活动性肝硬化)培养物中,脉冲培养基(P < 0.01)和追踪培养基(P < 0.001)中的GAG合成增加。数据表明,在缺乏免疫活性细胞或其分泌产物的情况下,体内活检显示有活动性纤维化证据的肝脏组织培养物在体外可能表现出胶原蛋白和GAG合成增加。酒精性肝炎培养物中增加的(可溶性)前胶原蛋白合成与体内组织学上可证实的明显肝纤维化无关,也与体外GAG合成增加无关。与各自对照组相比,含有300 mg/dl乙醇或3.75 mg/dl甲基泼尼松龙的配对培养物在胶原蛋白或GAG合成方面无明显差异。